Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.17%
1,102.46
+1.85
+0.17%
—1,100.611,106.151,114.281,100.55——
SIXC
Communications
SIXC
Communications
SIXC
+0.27%
613.96
+1.66
+0.27%
—612.30612.30616.23612.30——
SIXE
Energy
SIXE
Energy
SIXE
+0.83%
1,185.27
+9.81
+0.83%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.37%
1,722.79
-6.33
-0.37%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.18%
643.57
-1.16
-0.18%
—644.73645.31649.16642.92——
SIXR
Staples
SIXR
Staples
SIXR
+0.36%
830.07
+2.98
+0.36%
—827.09828.05833.90828.04——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.61%
213.51
-1.31
-0.61%
—214.82214.82216.61213.36——
SIXT
Technology
SIXT
Technology
SIXT
+1.68%
3,167.64
+52.47
+1.68%
—3,115.173,142.773,170.373,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.27%
912.90
+2.47
+0.27%
—910.43915.18923.94911.79——
SIXV
Health care
SIXV
Health care
SIXV
+0.33%
1,479.40
+4.90
+0.33%
—1,474.501,480.841,491.461,479.41——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.20%
2,401.04
-4.83
-0.20%
—2,405.872,415.572,420.792,399.55——
AEG:BCBA
Aegon Cedear
ARS 11,700.00
-0.85%
(-100.00) 1D
Apr 22, 11:35:03 AM GMT-3  ·   ARS
All symbols
SymbolPriceChange% Change
Generating top insights for AEG...
Open
ARS 11,740.00
High
ARS 11,800.00
Low
ARS 11,700.00
Mkt. cap
12.85B
Avg. vol.
461.00
Volume
50.00
52-wk high
ARS 12,520.00
52-wk low
ARS 6,690.00
Shares outstanding
1.57B
No. of employees
15K
News stories
From sources across the web
Profile
Aegon Ltd. is a Dutch public company for life insurance, pensions and asset management. It is headquartered in The Hague, Netherlands, and has 26,000 employees as of July 21, 2020. Aegon is listed on the Euronext Amsterdam and is a constituent of the AEX index. It also operated a direct bank under the brand name "Knab" in the Netherlands. In October 2022, it was announced that AEGON's Dutch operations would be acquired by ASR Nederland. To the extent they had the AEGON trade name, it will become ASR; Knab and TKP will keep their names. Subsequently, AEGON reincorporated in Bermuda. Wikipedia
About Aegon Cedear
CEOLard Friese
Employees15.3K
Founded1844
HeadquartersThe Hague, South Holland, Netherlands
SectorInsurance
Websiteaegon.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.33B
3.33B
2.77B
2.77B
Cost of goods sold
1.68B
1.68B
1.73B
1.73B
Cost of revenue
1.68B
1.68B
1.73B
1.73B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
124.50M
124.50M
159.00M
159.00M
Operating expense
1.28B
1.28B
1.03B
1.03B
Total operating expenses
2.96B
2.96B
2.76B
2.76B
Operating income
363.00M
363.00M
7.50M
7.50M
Other non operating income
-21.50M
-21.50M
88.00M
88.00M
EBT including unusual items
338.50M
338.50M
184.00M
184.00M
EBT excluding unusual items
342.50M
342.50M
177.50M
177.50M
Income tax expense
36.00M
36.00M
-3.50M
-3.50M
Effective tax rate
10.64%
10.64%
-1.90%
-1.90%
Other operating expenses
1.15B
1.15B
872.50M
872.50M
Net income
292.00M
292.00M
196.50M
196.50M
Net profit margin
8.78%
8.78%
7.09%
7.09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-88.00M
-88.00M
-80.50M
-80.50M
Net interest expenses
-88.00M
-88.00M
-80.50M
-80.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-4.00M
-4.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer